Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a Three Dimensional Functional Metabolic Imaging and Risk Assessment System for Classifying Women at High Risk of Breast Cancer

NCT02777164 is registered in ClinicalTrials.gov with Real Imaging Ltd. as lead sponsor.

NCT NCT02777164
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02777164 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a Three Dimensional Functional Metabolic Imaging and Risk Assessment System for Classifying Women at High Risk of Breast Cancer
Lead sponsor
Real Imaging Ltd.
Phase
Not applicable
Overall status
Terminated
Start date
May 31, 2016
Completion date
October 31, 2018
Enrollment
740 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer